| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_365ef8e353c8e4ac17036cd20a7b655c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_523523e4857f980c860a0d49e77ed0ec |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-102
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-988 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6883 |
| filingDate |
2018-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0ea6e2b41f90a598acc957bb2908d18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c75274d75c370577bac34a77369340e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e95f170706cd6797d7b33852ff0d4ca2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab91dc678667422567a4963f6290c1b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_deaa9f31c1e3c86d2f73ab23c9ae847b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d3047752086ac5ba85cbef6f1ba8a73 |
| publicationDate |
2020-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2020225248-A1 |
| titleOfInvention |
Mmp-8 as a marker for identifying infectious disease |
| abstract |
The invention relates to a method for the diagnosis, prognosis, risk assessment, risk stratification, monitoring, therapy guidance and/or therapy control of an infectious disease in a subject, wherein said method comprises providing a sample of said subject; determining a level of matrix metalloprotease-8 (MMP-8) or fragment(s) thereof in a sample of said subject, wherein said level of MMP-8 or fragment(s) thereof distinguishes between the presence and absence of an infectious disease in a patient with symptoms of a systemic inflammatory condition. In a preferred embodiment the invention relates to the determination of procalcitonin (PCT) and MMP-8 and their combined use to distinguish between the presence and absence of infectious disease in patients with symptoms of systemic inflammatory condition. The invention also relates to a computer-implemented method and a kit for conducting the method of the invention. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022229442-A3 |
| priorityDate |
2017-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |